Stay updated on MK-2640 Safety and Efficacy in Diabetes Clinical Trial
Sign up to get notified when there's something new on the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page.

Latest updates to the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page
- Check6 days agoChange DetectedPage footer shows a revision update: v3.3.3 was replaced by v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedFooter updated to Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check56 days agoChange DetectedUpdated the Publications note to say publications are provided voluntarily by the person who enters information about the study and are about the results of the study, and added Revision: v3.3.2. Removed the older Publications note phrasing and the Revision: v3.2.0.SummaryDifference0.1%

- Check63 days agoChange DetectedThe notice about lapse in government funding and NIH operating status was removed from the page, a minor UI/content change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check77 days agoChange DetectedThere are no significant changes to the study details; the updates appear to be visual/layout adjustments and minor wording edits that do not alter core information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check106 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

Stay in the know with updates to MK-2640 Safety and Efficacy in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page.